A Isomorphic Labs é uma empresa da Alphabet que utiliza uma abordagem 'AI-first' para acelerar e reimaginar o processo de descoberta de medicamentos, visando projetar novos medicamentos e, em última análise, resolver todas as doenças.
Por que importa
API disponível
overview
A Isomorphic Labs é uma ferramenta de descoberta de medicamentos impulsionada por IA, desenvolvida pela Alphabet Inc., que permite a empresas farmacêuticas e biomédicas projetar novos medicamentos. Ela aproveita o aprendizado de máquina avançado, incluindo a tecnologia AlphaFold, para prever e gerar formas e sequências de proteínas em nível atômico.
features
A Isomorphic Labs emprega um motor unificado de design de medicamentos por IA para acelerar e reimaginar o processo de descoberta de medicamentos, oferecendo um conjunto de capacidades para design molecular e previsão de interações.
use cases
A Isomorphic Labs visa principalmente entidades e especialistas envolvidos em pesquisa e desenvolvimento farmacêutico avançado, buscando aproveitar a IA para uma descoberta de medicamentos acelerada e mais precisa.
pricing
A Isomorphic Labs opera em um modelo freemium para sua tecnologia central, especificamente com AlphaFold 3 estando disponível gratuitamente para pesquisa não comercial. O acesso comercial ao motor proprietário de design de medicamentos por IA da Isomorphic Labs e suas capacidades avançadas é facilitado principalmente através de colaborações estratégicas de pesquisa multi-alvo e parcerias com empresas farmacêuticas e biomédicas, em vez de níveis de assinatura pública.
Ferramentas similares
A Isomorphic Labs se distingue no cenário da descoberta de medicamentos por IA através de sua herança DeepMind e foco na redução da dependência de laboratórios úmidos via simulação computacional, contrastando com as abordagens variadas dos concorrentes.
Generate Biomedicines uses a generative AI platform to design novel protein therapeutics from scratch, focusing on a diverse range of therapeutic modalities.
Similar to Isomorphic Labs, Generate Biomedicines focuses on de novo protein design for drug discovery. Their platform emphasizes generating a broader spectrum of therapeutic modalities, whereas Isomorphic Labs explicitly mentions predicting and generating protein shapes and sequences. Pricing is likely enterprise-based, contrasting with Isomorphic Labs' stated freemium model.
Xaira Therapeutics integrates cutting-edge AI research, including technologies like RFdiffusion, with therapeutic development to design novel proteins and antibodies for complex biological challenges.
Like Isomorphic Labs, Xaira Therapeutics leverages advanced AI for protein and antibody design in drug discovery. Xaira appears to have a strong focus on integrating academic AI breakthroughs directly into therapeutic development, potentially offering a broader range of AI models for novel protein and antibody generation.
Latent Labs is building generative AI models for de novo protein design, with a focus on creating entirely new therapeutic molecules like antibodies and enzymes to make biology more programmable.
Latent Labs directly competes with Isomorphic Labs in the de novo protein design space, aiming to generate entirely new therapeutic molecules. Their approach emphasizes a predominantly digital workflow with wet lab validation, aligning with Isomorphic's AI-first strategy for drug discovery.
DenovAI offers an AI-driven platform, AlphaDesign, capable of creating new, functional synthetic proteins entirely de novo without requiring training on evolutionary data or using known protein templates.
DenovAI is a direct competitor to Isomorphic Labs, both aiming to design novel proteins from scratch using AI. DenovAI highlights its ability to generate synthetic proteins without evolutionary templates, potentially offering a distinct approach to sequence and structure generation compared to Isomorphic Labs' methods.
ProteinQure specializes in the AI-driven design of novel exotic peptides with broad therapeutic applications, leveraging its ProteinStudio™ computational platform for de novo peptide design and tissue-specific delivery.
ProteinQure, through its ProteinStudio™ platform, directly competes with Isomorphic Labs in AI-driven protein/peptide design for drug discovery. Its unique focus on exotic peptides and clinical-stage development for targeted delivery differentiates its therapeutic application, while Isomorphic Labs focuses more broadly on protein shapes and sequences.
AI Reputation Report
ChatGPT, Perplexity, Gemini, Claude & Grok answer buyer questions about Isomorphic Labs every day. See whether they name Isomorphic Labs — or send buyers to a rival.
